Compare HYFM & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYFM | IRIX |
|---|---|---|
| Founded | 1977 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 20.2M |
| IPO Year | 2020 | 1996 |
| Metric | HYFM | IRIX |
|---|---|---|
| Price | $2.16 | $0.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.6K | 59.3K |
| Earning Date | 11-12-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,443,000.00 | $50,647,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | $37.86 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $1.50 | $0.78 |
| 52 Week High | $7.50 | $1.89 |
| Indicator | HYFM | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 50.02 |
| Support Level | $1.51 | $0.92 |
| Resistance Level | $2.54 | $0.98 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 52.85 | 41.03 |
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.